February 2026 · Zohaib Akhtar

Clinical AI mein Bayesian Inference ka Asal Matlab

Aage ki taraf reasoning vs peeche ki taraf matching

Ye English mein likha gaya, phir Chroneme ke language module ne ise context ke hisaab se translate kiya. Galtiyan ho sakti hain; English original hi reference hai. Original padhein

Test is ummeed mein order nahi hota ki wo positive aaye

Jab ek physician troponin order karti hai, toh wo ye nahi pooch rahi ki "kya is patient ko heart attack hai?" Wo pooch rahi hai ki "is result ke hisaab se mujhe apni soch kitni update karni chahiye?" Ye do alag sawaal hain.

Test order hone se pehle hi uske paas ek andaaza hota hai. Ek 62 saal ka aadmi, jiska chest pain left arm tak jaa raha hai aur saath mein diaphoresis hai, uski acute coronary syndrome ki pre-test probability high hai. Ek 28 saal ki aurat, wahi chief complaint, lekin teen espresso peene ke baad, uski low hai. Troponin result ka matlab dono ke liye alag hai. Pehle patient mein mildly elevated troponin wahi confirm karta hai jiska use pehle se shak tha. Doosre patient mein wahi result zyada sambhavna se false positive hai, kyunki test khud perfect nahi hai, aur jab aap ek imperfect test kisi aise insaan pe lagate hain jise shayad wo condition nahi hai, toh math aapke khilaaf kaam karta hai.

Har test ki ek sensitivity aur ek specificity hoti hai. Sensitivity batati hai ki bimari sach mein ho toh test use kitni baar pakadta hai. Specificity batati hai ki jise bimari nahi hai, use test kitni baar sahi se clear karta hai. Koi bhi test dono mein 100% nahi hai. 95% sensitivity wala test bhi 5% asli cases miss karta hai. 90% specificity wala test bhi 10% healthy logon ko galat flag karta hai. Ye numbers test ki properties hain, patient ki nahi. Aur inka matlab hai ki har result mein ek uncertainty hoti hai jo aapke confidence ko badalni chahiye, uski jagah nahi leni chahiye.

Bayesian reasoning yahi hai. Aap us cheez se shuru karte hain jo patient ke baare mein pehle se jaante hain. Aapko ek nayi jaankari milti hai. Wo jaankari kitni reliable hai, uske hisaab se aap apna andaaza update karte hain. Phir agli jaankari ke saath yahi dobara karte hain.

Zyadatar clinical AI iska ulta karta hai

Healthcare mein zyadatar AI systems peeche ki taraf kaam karte hain. Wo results ka ek collection lete hain, vitals, labs, diagnoses, medications, aur unhe training data se seekhe patterns se retrospectively match karte hain. System dekhta hai creatinine 1.6, diabetes ki history, medication list mein ek ACE inhibitor, aur output deta hai "likely CKD", kyunki jin cases pe wo train hua tha unmein features ka ye combination aksar saath dikha tha.

Ye theek lagta hai jab tak aap ye na sochein ki kya missing hai. System nahi jaanta ki creatinine badh raha hai ya stable hai. Wo nahi jaanta ki ACE inhibitor kidney protection ke liye diya gaya tha ya blood pressure ke liye. Wo nahi jaanta ki do saal pehle patient ka creatinine 0.9 tha aur tab se lagataar chadh raha hai. Wo is baat ka hisaab nahi rakhta ki is population mein urine albumin test ka false positive rate 15% hai. Wo bas aaj ke snapshot ko purane patterns se match karta hai aur ek label de deta hai.

Wahi patient dekhne wali physician aage ki taraf reasoning karegi. Wo patient ki umar, sex aur risk factors ke hisaab se CKD ki prior probability se shuru karegi. Creatinine ke basis pe update karegi, lekin us update ko is baat se tolegi ki ek akele creatinine measurement pe use kitna bharosa hai. Wo trend dekhegi, sirf aaj ka number nahi. Wo ACE inhibitor ko consider karegi, lekin kidney disease ka evidence maanne se pehle poochegi ki wo diya kyun gaya. Har evidence probability ko hilata hai, aur har ek ko is hisaab se wazan milta hai ki wo kitna reliable hai.

Retrospective approach poochta hai: ye kis jaisa dikhta hai? Prospective approach poochta hai: ab tak jo kuch hum jaante hain uske hisaab se ye nayi jaankari humein kya batati hai, aur us pe kitna bharosa karna chahiye?

Poore patient ko dekhna vs results ko dekhna

Clinical training mein sabse pehle seekhi jaane wali baaton mein se ek ye hai ki ilaaj patient ka hota hai, lab ka nahi. Hemolyzed sample mein 5.8 potassium ka koi matlab nahi. Jo patient abhi daud kar appointment pe pahuncha hai, uska 160 blood pressure hypertension nahi hai. Context tay karta hai ki result signal hai ya noise, aur context ke liye patient ko aaj ke chart se aage jaanna padta hai.

Ek general-purpose AI results process karta hai. Wo numbers, notes, coded diagnoses padhta hai aur textual patterns ke basis pe output deta hai. Wo ismein bahut achha hai. Wo kisi bhi insaan se tez discharge note summarize kar sakta hai. Bikhre hue clinical text se structured data nikaal sakta hai. Lekin wo chart waise padh raha hai jaise aap textbook mein case study padhte hain. Sab ho jaane ke baad.

Real time mein patient dekh rahi physician kuch alag kar rahi hai. Wo uncertainty ke beech, time mein aage ki taraf reasoning kar rahi hai, har nayi jaankari aane pe apna assessment update kar rahi hai, aur har jaankari ko utna wazan de rahi hai jitna us pe bharosa hai. Wo jaanti hai ki low-risk patient mein positive D-dimer shayad false positive hai. Wo jaanti hai ki normal chest X-ray early pneumonia ko rule out nahi karta. Prior probability uske dimaag mein rehti hai aur wo har finding ke saath use adjust karti hai, barabar nahi, balki har finding ki diagnostic value ke hisaab se.

Jab humne Chroneme banaya, toh hum chahte the ki system waise soche jaise wo sochti hai, waise nahi jaise ek search engine. Aage ki taraf, peeche ki taraf nahi. Har naye evidence ke saath probabilities update karte hue, is hisaab se wazan dekar ki wo evidence asal mein kitna reliable hai.

Practice mein ye kaise kaam karta hai

Type 2 diabetes wala ek 58 saal ka aadmi routine labs ke liye aata hai. Umar, sex aur diabetes diagnosis ke basis pe uski chronic kidney disease ki baseline probability ek level pe shuru hoti hai. Zero nahi, kyunki CKD ki sabse badi wajah diabetes hai. High bhi nahi, kyunki use koi symptoms nahi hain aur pehle koi kidney findings nahi hain.

Uska creatinine 1.2 aata hai. Technically ye normal range mein hai, lekin pichhle result se zyada hai. System update karta hai. Zyada nahi, kyunki ek thoda sa elevated creatinine ki diagnostic value modest hoti hai. CKD ke liye ek akele creatinine ki sensitivity aur specificity apne aap mein kuch khaas strong nahi hain.

Das mahine baad uska creatinine 1.4 hai aur eGFR 60 se neeche gir gaya hai. Ab update bada hai, kyunki 60 se neeche eGFR ki CKD ke liye diagnostic value kaafi zyada hai. Lekin system wo bhi dekhta hai jo ek static model nahi dekh sakta: trajectory. Creatinine sirf elevated nahi hai. Wo is raftaar se badh raha hai ki aage project karo toh ek chinta wali range mein pahunchta hai.

Ek saal baad proteinuria aa jaata hai. Ab probability itni high hai ki action lena banta hai. Lekin clinically jo hissa matter karta hai wo ye hai: system proteinuria aane se mahino pehle se is patient ko flag kar raha tha. Certainty ke saath nahi. Ek aisi probability ke saath jo is tarah chadh rahi thi ki dhyan dena zaroori tha. Chart review kar rahi physician har update dekh sakti hai, dekh sakti hai ki use kisne chalaya, aur tay kar sakti hai ki wo agree karti hai ya nahi. Agar use lagta hai ki ACE inhibitor kidneys ke liye nahi, blood pressure ke liye diya gaya tha, toh wo apne clinical judgment mein us factor ko alag wazan de sakti hai. System apni reasoning dikhata hai. Wo apni reasoning lagati hai.

Trajectory khud evidence ban jaati hai, kisi ek number se alag.

Bharose ke liye ye kyun matter karta hai

Jab ek neural network kehta hai "CKD ka 73% chance", toh ye poochne ka koi tareeka nahi ki kyun. Wo number lakhon parameters se nikalta hai jo kisi clinical concept se match nahi karte. Physician use dekh kar ye nahi keh sakti ki "creatinine wale hisse se main agree karti hoon, lekin medication history ko aap zyada wazan de rahe ho." Koi creatinine wala hissa hai hi nahi. Koi medication wala hissa nahi. Bas ek number hai.

Jab ek Bayesian system 73% kehta hai, toh physician pooch sakti hai kyun. Wo dekh sakti hai ki kis evidence ne probability ko hilaya aur kitna. Wo kisi khaas factor se disagree karke apna judgment laga sakti hai. Yahi baatcheet hai jisse clinical AI asal mein care badalta hai. Iske bina output ek daava hai. Iske saath output ek daleel hai.

Ek nephrologist, jise humne system dikhaya, unhone ye baat saaf saaf kahi. Unhone ek patient ki evidence chain dekhi aur kaha ki wo zyadatar se agree karte hain, lekin unke hisaab se ek factor ko zyada wazan mil raha tha, kyunki prescribing context wo nahi tha jo system maan raha tha. Wo sahi the. Aur ye ki wo ye observation kar sake, us khaas factor ki taraf ishara kar sake, aur apni expertise laga sake, yahi to clinical decision support ko mumkin banana chahiye. Black box unhe wahi probability deta, lekin ye baatcheet karne ka koi raasta nahi hota.

Wo limitations jin ke baare mein hum imaandaar hain

Bayesian inference maan ke chalta hai ki disease di hui ho toh evidence items conditionally independent hain. Clinical medicine mein aksar aisa nahi hota. CKD ke context mein creatinine aur proteinuria correlated hain. Ye ek jaani hui limitation hai, aur ise perfectly solve karna field mein ek open problem hai.

Output ki quality evidence weights ki quality pe depend karti hai. Kuch published literature mein achhi tarah established hain. Baaki approximations hain jinhe hum validation ke through refine karte hain. Calibration lagataar chal raha hai, aur hum iske ulat koi dikhava nahi karte.

Bayesian inference structured, quantifiable evidence achhe se handle karta hai: labs, vitals, medications, coded diagnoses. Unstructured clinical notes aur patient-reported symptoms ko utna achhe se nahi. Alag tarah ke clinical data ke liye hum alag approaches use karte hain, problem ke hisaab se tool chunte hain.

Humne Bayesian inference isliye chuna kyunki physicians pehle se isi tarah sochte hain. Ek achha clinician jo intuitively karta hai, system use formal bana deta hai, scale pe, har patient ke liye, lagataar. Bas itna hi. Koi jaadu nahi. Sirf clinical reasoning ke peeche ka math, saaf saaf likha hua.

Zohaib Akhtar
Zohaib Akhtar
MD · Co-founder, Chroneme